Inventor · disambiguated record
Mats A. Svensson
Also filed as: SVENSSON MATS · SVENSSON MATS A
18 granted patents·9 pending applications·58 citations·filing 2004–2025
93Inventor score
Files withMORPHIC THERAPEUTIC INC16ONO PHARMACEUTICAL CO4ASTRAZENECA AB3ACTURUM REAL ESTATE AB2HARRISON BRYCE A1
Top patents by PatentIndex Score
27 records- 0196US12145935B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2023·Granted Nov 19, 2024·4 cites·20 claims
- 0296US11795167B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2021·Granted Oct 24, 2023·5 cites·19 claims
- 0395US11827621B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2021·Granted Nov 28, 2023·5 cites·9 claims
- 0494US12415796B2Inhibitors of (αv)(β6) integrinMORPHIC THERAPEUTIC INC·Filed 2023·Granted Sep 16, 2025·2 cites·8 claims
- 0594US11739087B2Inhibiting (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2021·Granted Aug 29, 2023·5 cites·9 claims
- 0694US11046669B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2019·Granted Jun 29, 2021·8 cites·35 claims
- 0793US11046685B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2018·Granted Jun 29, 2021·8 cites·42 claims
- 0893US11040955B2Inhibitors of (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2018·Granted Jun 22, 2021·8 cites·59 claims
- 0993US10759756B2Antagonists of human integrin α4β7MORPHIC THERAPEUTIC INC·Filed 2019·Granted Sep 1, 2020·7 cites·42 claims
- 1091US11691968B2Compound having KDM5 inhibitory activity and pharmaceutical use thereofONO PHARMACEUTICAL CO·Filed 2022·Granted Jul 4, 2023·2 cites·3 claims
- 1185US12459942B2Inhibiting (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2024·Granted Nov 4, 2025·0 cites·18 claims
- 1285US12221416B2Antagonists of human integrin α4β7MORPHIC THERAPEUTIC INC·Filed 2023·Granted Feb 11, 2025·0 cites·20 claims
- 1384US2025223289A1Inhibitors of (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2024·Application pending·0 cites
- 1483US11174228B2Antagonists of human integrin (α4)(β7)MORPHIC THERAPEUTIC INC·Filed 2020·Granted Nov 16, 2021·1 cites·20 claims
- 1579US12269817B2Compound having KDM5 inhibitory activity and pharmaceutical use thereofONO PHARMACEUTICAL CO·Filed 2023·Granted Apr 8, 2025·0 cites·3 claims
- 1672US2022340529A1Antagonists of human integrin (alpha4)(beta7)MORPHIC THERAPEUTIC INC·Filed 2021·Application pending·0 cites
- 1768US2025214984A1Compound having kdm5 inhibitory activity and pharmaceutical use thereofONO PHARMACEUTICAL CO·Filed 2025·Application pending·0 cites
- 1868US2020071322A1Inhibiting (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2019·Application pending·0 cites
- 1967US2020354359A1Inhibiting (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2020·Application pending·0 cites
- 2062US7645784B2Benzimidazole derivativesASTRAZENECA AB·Filed 2004·Granted Jan 12, 2010·3 cites·9 claims
- 2151US2023219949A1Inhibitors of (alpha-v)(beta-6) integrinHARRISON BRYCE A·Filed 2022·Application pending·0 cites
- 2248US2022289751A1Compound having kdm5 inhibitory activity and pharmaceutical use thereofONO PHARMACEUTICAL CO·Filed 2020·Application pending·0 cites
- 2345US2007093483A1Use of derivatives of 2, 4-dihydro-[1,2,4] triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo)ASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 2442US8859556B2TRPA1 receptor antagonistSVENSSON MATS·Filed 2011·Granted Oct 14, 2014·0 cites·7 claims
- 2542US2009291983A13-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic AgentsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2634US10227296B2Bis(sulfonamide) derivatives and their use as mPGES inhibitorsACTURUM REAL ESTATE AB·Filed 2015·Granted Mar 12, 2019·0 cites·25 claims
- 2723US10081614B2Bis(sulfonamide) derivatives and their use as mPGES inhibitorsACTURUM REAL ESTATE AB·Filed 2015·Granted Sep 25, 2018·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Mats A. Svensson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →